XOLAIR 150mg|ml Injection Vial

Frequently asked questions

• Onset of action

  This medicine is used for the treatment of chronic idiopathic urticaria (hives) without a known cause in patients who have not responded successfully with antihistamine treatment.

• Duration of Effect

  The amount of time for which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit-forming tendencies were reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to XOLAIR 150mg|ml Injection Vial or any other inactive ingredients present along with it.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

• Use in children

  The safety and efficacy of XOLAIR 150mg|ml Injection Vial for the management of allergic asthma is not clinically established in children below 6 years of age. In chronic idiopathic urticaria, safety and efficacy of XOLAIR 150mg|ml Injection Vial is not clinically established in children below 12 years of age.

• Anaphylaxis

  This medicine may cause severe anaphylactic reactions presenting as bronchospasm, hypotension, syncope, urticaria, and/or angioedema of the throat or tongue, etc. in some patients. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

• Parasitic infections

  This medicine should be used with extreme caution in patients at high risk of geohelminth infection due to the risk of worsening of the patient's condition. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

• Usage does not depend on food timings
• To be taken as instructed by doctor
• Effect on sleep is not established

• medlineplus.gov - Omalizumab [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a603031.html [cited 9/9/2020]. 2020